This also suggests that because TMPRSS2 is already upregulated in PRAD patients, the patients show increased susceptibility towards SARS-CoV-2 infection as an upregulation of TMPRSS2 will promote ACE2 priming [28,68,69]. The gene discussed is ACE2; the disease is prostate adenocarcinoma.